Page 7 - Flu Lab News Today

Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.

Using protein structures generated by the AI software AlphaFold, MIT researchers investigated whether existing computational models could identify the mechanisms of action of antibacterial compounds.

A new study performed by the scientists at the University of Michigan (U-M) has proved the fact that testing the durability of new electric vehicle battery designs could be four times quicker with a smooth approach.

The eventual answers to these Covid mysteries will determine our relationship with Covid and and how we'll fight a future pandemic.

In January, the Centers for Disease Control and Prevention (CDC) updated its guidance for reducing SARS-CoV-2 (COVID-19) transmission in schools and day care settings.

A new algorithm could one day notify smartwatch wearers of stress, capturing events such as air travel, extended exercise, and illness—including COVID-19.

The Philly Vax Sweepstakes awarded 12 cash prizes to city residents after the first drawing was held on June 21. Two people received $50,000 prizes for getting their COVID-19 vaccination. The second drawing, which will include another 12 cash prizes, will be held July 6. The third and final drawing will be on July 19.

email article Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene. MedPage Today explores how the old antidepressant has made its way to the COVID spotlight. Fluvoxamine and the COVID Early Treatment Fund Fluvoxamine is the poster child o...

1 year into COVID: What we wish we’d known 4 takeaways we wish we’d known from day 1 Frank McGeorge, MD, Local 4s Good Health Medical Expert Updated:  Tags:  READ: READ: Ad From the start, health experts believed the SARS-CoV-2 virus would act similar to the previous coronaviruses that caused SARS and MERS. Experts estimate that about half of all COVID cases are spread by people who are asymptomatic or presymptomatic. At first, masks were only recommended for those who were sick, but nu...

Early last year, Angela Reiersen, a psychiatrist at Washington University in St. Louis, took ill with what she suspected was COVID-19. Because of a shortage of tests at the time, she never found out for sure, and she recovered before long. But the experience got her thinking about something. Reiersen had recently seen research suggesting that an antidepressant called fluvoxamine was useful in treating sepsis, a potentially fatal condition in which the body releases a dangerous imbalance of chem...